Breakthrough in COVID-19 Testing: DRAP Approves First Pakistani Local Testing Kit
The National University of Science and Technology (NUST) has achieved a significant milestone in the fight against COVID-19, with the Drug Regulatory Authority of Pakistan (DRAP) approving its locally developed COVID-19 testing kit, N-CovKit. This breakthrough was announced by Federal Minister of Science and Technology, Fawad Chaudhary, marking a major success for Pakistani scientists and researchers.
Addressing the Need for Local Testing Solutions
The increasing number of COVID-19 cases in Pakistan, combined with the depletion of medical resources, has highlighted the need for domestic testing solutions. The development of local test kits is crucial in helping Pakistan combat the pandemic, reducing reliance on imported kits, and enhancing the country’s testing capacity. The approval of N-CovKit is a significant step towards achieving this goal.
The Minister for Science and Technology, Fawad Hussain, congratulated the scientists behind the development of N-CovKit, stating that the test kits will lead to a significant reduction in COVID-19 testing costs in the country. He also emphasized that the local production of test kits will save the country from incurring huge import costs, making testing more accessible and affordable for the population.
The Scientists Behind the Achievement
The N-CovKit was developed by a team of young scientists from the NUST Atta-ur-Rahman School of Applied Life Sciences (ASAB), led by Associate Professor Dr. Aneela Javed and Associate Professor Dr. Ali Zohaib. The team has been working tirelessly on the diagnosis kit since the pandemic outbreak and announced its development in mid-March. The approval from DRAP is a testament to their dedication and hard work.
Dr. Aneela Javed expressed her excitement about the approval, stating that it is a great achievement for Pakistani scientists. She hopes that the diagnostic test will be available in the market soon, enabling widespread testing and helping to combat the pandemic more effectively.
Collaboration and Support
The development of N-CovKit was made possible through collaboration with international institutions, including the Wuhan Institute of Virology, China, DZIF Germany, Columbia University, USA, and the Armed Forces Institute of Pathology (AFIP) Rawalpindi. The researchers also appreciated the support received from the National Institute of Health (NIH) during the trial phase.
Increasing Testing Capacity
The locally developed test kits are expected to significantly increase Pakistan’s testing capacity, which is crucial for detecting infected individuals and containing the spread of the virus. With the approval of N-CovKit, Pakistan can now enhance its testing capabilities, enabling healthcare authorities to identify and isolate infected cases more efficiently.
According to the latest statistics, Pakistan has reported 6,472 COVID-19 cases and 88 deaths in the past 24 hours, bringing the national total to 132,405 cases and 2,551 deaths. A total of 839,019 COVID-19 tests have been conducted to date.
FAQs
- What is N-CovKit, and how does it work?
- How will the approval of N-CovKit impact COVID-19 testing in Pakistan?
- When will N-CovKit be available in the market?
N-CovKit is a locally developed COVID-19 testing kit that uses a molecular diagnostic technique to detect the presence of the SARS-CoV-2 virus in patient samples.
The approval of N-CovKit will increase Pakistan’s testing capacity, enabling more widespread testing and helping to combat the pandemic more effectively.
N-CovKit is expected to be available in the market soon, once mass production begins. The exact timeline will depend on the commercial production contract awarded by DRAP.
With the approval of N-CovKit, Pakistan has taken a significant step towards enhancing its COVID-19 testing capabilities. The development of local test kits is a testament to the country’s scientific expertise and its ability to respond to the pandemic effectively. As the country continues to battle the pandemic, the availability of affordable and reliable testing solutions will play a critical role in containing the spread of the virus and saving lives.
